Showing results (1-10 of 451) with videos related to
Sort By:
Pageof 46
Expert Opinion on Investigational Drugs|May 20, 2011
Clofarabine for myelodysplastic syndromesRamon V Tiu, Fabiola Traina, Mikkael A SekeresExpert Opinion on Biological Therapy|June 14, 2008
The role of AMG-531 in the treatment of thrombocytopenia in idiopathic thrombocytopenic purpura and myelodysplastic syndromesRamon V Tiu, Mikkael A SekeresCurrent Opinion in Hematology|January 1, 2014
Making sense of the myelodysplastic/myeloproliferative neoplasms overlap syndromesRamon V Tiu, Mikkael A SekeresSAGE Open Medical Case Reports|August 5, 2016
A case of mistaken identity: When lupus masquerades as primary myelofibrosisEdy Hasrouni, Heesun J Rogers, Ali Tabarroki, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Myelodysplastic syndromes: recent advancements in risk stratification and unmet therapeutic challengesRafael Bejar, Ramon V Tiu, Mikkael A Sekeres, et al.Expert Review of Hematology|February 5, 2013
The need for additional genetic markers for myelodysplastic syndrome stratification: what does the future hold for prognostication?Zaher K Otrock, Ramon V Tiu, Jaroslaw P Maciejewski, et al.Current Hematologic Malignancy Reports|February 23, 2011
Updates in cytogenetics and molecular markers in MDSRamon V Tiu, Valeria Visconte, Fabiola Traina, et al.Best Practice & Research. Clinical Haematology|November 24, 2018
The role of hypomethylating agents prior to hematopoietic cell transplantation in myelodysplastic syndromesMikkael A SekeresExpert Opinion on Biological Therapy|February 21, 2007
The myelodysplastic syndromesMikkael A SekeresCurrent Hematology Reports|December 22, 2004
Arsenic trioxide as a treatment for myelodysplastic syndromeMikkael A SekeresPageof 46